Actively Recruiting
Microwave Ablation With Splenic Artery Occlusion for Secondary Hypersplenism
Led by Tianjin Medical University Cancer Institute and Hospital · Updated on 2024-03-05
35
Participants Needed
1
Research Sites
153 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study assesses the effectiveness of microwave ablation of the spleen in conjunction with splenic artery occlusion for treating secondary hypersplenism.
CONDITIONS
Official Title
Microwave Ablation With Splenic Artery Occlusion for Secondary Hypersplenism
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Signed written informed consent before joining the study
- Age over 18 years, any gender
- Severe secondary hypersplenism caused by cirrhosis with clinical diagnosis
- White blood cell count less than 3 x 10⁹/L and/or platelet count less than 50 x 10⁹/L
- Poor response to repeated drug treatments aimed at raising white blood cells and platelets
- Mental or clinical symptoms such as anxiety requiring interventional treatment for hypersplenism
You will not qualify if you...
- Presence of blood clotting problems or other blood disorders
- Recent use of anticoagulant medications
- Severe high blood pressure or heart failure
- Bone marrow suppression shown by bone marrow aspiration
- Other malignant diseases affecting the spleen
- Severe skin infection at the site where puncture would occur
- Participation in another clinical study within 2 months before this study
- Unwillingness to sign informed consent or follow the study protocol
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Tianjin Medical University Cancer Institute & Hospital
Tianjin, Tianjin Municipality, China, 300060
Actively Recruiting
Research Team
W
WEI LU, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here